CICON23 in Milan
CICON23 in Milan, Italy will provide an unparalleled opportunity for teaching, learning, and networking among all stakeholders in the field: scientists, clinicians, regulators, drug developers, and patient advocates.
The CICON conference series is a collaboration between the Cancer Research Institute (CRI), the European Network for Cancer Immunotherapy (ENCI), and the American Association of Cancer Research (AACR).
Take a look at the program or to www.cancerimmunotherapyconference.org for more information
Confirmed speakers:
Jim Allison, The University of Texas MD Anderson Cancer Center (USA) / Lisa Coussens, Knight Cancer Institute (USA) / Eric Vivier, Aix Marseille Université - INSERM - CNRS (France) / Shannon Turley, Genentech (USA) / Andrea Schietinger, Sloan Kettering Institute (USA) / Yifat Merbl, Weizmann Institute (Israel) / Catherine Sautès-Fridman, University Paris Cité (France) / Marina Garassino, University of Chicago (USA) / Sergio Quezada, UCL Cancer Institute – University (UK) / Dieter Lambrecht, KU Leuven Center for Cancer Biology (Belgium) / Marleen Kok, Netherlands Cancer Institute (The Netherlands) / Fatima Mechta-Grigoriou, Institut Curie (France) / Alberto Mantovani, Humanitas Research Insitute (Italy) / Padmanee Sharma, MD Anderson Cancer Center (USA) / Christian Blank, The Netherlands Cancer Institute (The Netherlands) / Tina Cascone, MD Anderson Cancer Center (USA) / Nir Hacohen, Harvard Medical School (USA) / Aaron Newman, Stanford Cancer Institute (USA) / Joakim Lundeberg, KTH Royal Institute of Technology (Sweden) / Andrea Alimonti, Università della Svizzera Italiana (Switzerland) / Vincenzo Bronte, Istituto Oncologico Veneto (Italy) / Ozlem Tureci, BioNTech (Germany) / Tom Gajewski, The University of Chicago (USA) / Paolo Ascierto, Università degli Studi di Napoli Federico II (Italy) / Jeffrey Weber, NYU Langone New York (USA) / Susan Kaech, Salk Institute for Biological Studies (USA) / Antonio Sica, Humanitas University (Italy) / Greg Delgoffe, University of Pittsburgh (USA) / Arlene Sharpe, Harvard Medical School (USA) / Paola Nisticò, IFO Regina Elena National Cancer Institute (Italy) / Ira Mellman, Genentech (USA) / Antoni Ribas, University of California Los Angeles (USA) / Chiara Bonini, IRCCS Ospedale San Raffaele (Italy) / Max Topp, Universitätsklinikum Würzburg (Germany) / Matteo Bellone - IRCCS Ospedale San Raffaele (Italy) / Florencia McAllister, MD Anderson Cancer Center (USA)v/ Laurence Zitvogel, Gustave Roussy Cancer Campus (France) / Kathy McCoy - University of Calgary (Canada) / Cassian Yee - University of Texas (USA) / Giampietro Dotti - University of North Carolina Lineberger Comprehensive Cancer